Improvement in the performance of external quality assessment in Korean HIV clinical laboratories using unrecalcified human plasma

Jin Sook Wang, Mee Kyung Kee, Byeong Sun Choi, Chan Wha Kim, Hyon Suk Kim, Sung Soon Kim

Research output: Contribution to journalArticle

Abstract

Background: The external quality assessment schemes (EQAS) organizer provides a suitable program to monitor and improve the quality of human immunodeficiency virus (HIV) testing laboratories with EQAS panels prepared under various conditions. The aim of the current study was to investigate the effects of human plasma samples on the EQAS results of HIV obtained from hospital-based clinical laboratories. Methods: From 2007 to 2009, HIV EQAS panels consisted of four to six samples that consisted of undiluted positive and negative samples and were provided to laboratories twice per year. Up until the first half EQAS in 2008, EQAS panel materials were obtained by converting acid citrate dextrose treated plasma to serum via chemical treatment with CaCl 2. Beginning with the second EQAS in 2008, all materials were prepared without the defibrination process. Results: Approximately 300 HIV clinical laboratories participated in this program. The overall performance of clinical laboratories was shown to be improved when using unrecalcified plasma panels compared with recalcified panels. Significant differences were observed in EIA analyses of plasma for both positive (p < 0.001) and negative (p < 0.001) samples between the recalcified and unrecalcified groups. Conclusions: Our finding suggested that defibrination status of EQAS panels might affect the results of anti-HIV EQAS of Korean HIV testing laboratories.

Original languageEnglish
Pages (from-to)1565-1571
Number of pages7
JournalClinical Chemistry and Laboratory Medicine
Volume50
Issue number9
DOIs
Publication statusPublished - 2012 Sep 1

Fingerprint

Clinical laboratories
Plasma (human)
Viruses
HIV
Plasmas
Testing
Serum

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Wang, Jin Sook ; Kee, Mee Kyung ; Choi, Byeong Sun ; Kim, Chan Wha ; Kim, Hyon Suk ; Kim, Sung Soon. / Improvement in the performance of external quality assessment in Korean HIV clinical laboratories using unrecalcified human plasma. In: Clinical Chemistry and Laboratory Medicine. 2012 ; Vol. 50, No. 9. pp. 1565-1571.
@article{8057dc117bf7406f8da6f41f1e004770,
title = "Improvement in the performance of external quality assessment in Korean HIV clinical laboratories using unrecalcified human plasma",
abstract = "Background: The external quality assessment schemes (EQAS) organizer provides a suitable program to monitor and improve the quality of human immunodeficiency virus (HIV) testing laboratories with EQAS panels prepared under various conditions. The aim of the current study was to investigate the effects of human plasma samples on the EQAS results of HIV obtained from hospital-based clinical laboratories. Methods: From 2007 to 2009, HIV EQAS panels consisted of four to six samples that consisted of undiluted positive and negative samples and were provided to laboratories twice per year. Up until the first half EQAS in 2008, EQAS panel materials were obtained by converting acid citrate dextrose treated plasma to serum via chemical treatment with CaCl 2. Beginning with the second EQAS in 2008, all materials were prepared without the defibrination process. Results: Approximately 300 HIV clinical laboratories participated in this program. The overall performance of clinical laboratories was shown to be improved when using unrecalcified plasma panels compared with recalcified panels. Significant differences were observed in EIA analyses of plasma for both positive (p < 0.001) and negative (p < 0.001) samples between the recalcified and unrecalcified groups. Conclusions: Our finding suggested that defibrination status of EQAS panels might affect the results of anti-HIV EQAS of Korean HIV testing laboratories.",
author = "Wang, {Jin Sook} and Kee, {Mee Kyung} and Choi, {Byeong Sun} and Kim, {Chan Wha} and Kim, {Hyon Suk} and Kim, {Sung Soon}",
year = "2012",
month = "9",
day = "1",
doi = "10.1515/cclm-2011-0943",
language = "English",
volume = "50",
pages = "1565--1571",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "9",

}

Improvement in the performance of external quality assessment in Korean HIV clinical laboratories using unrecalcified human plasma. / Wang, Jin Sook; Kee, Mee Kyung; Choi, Byeong Sun; Kim, Chan Wha; Kim, Hyon Suk; Kim, Sung Soon.

In: Clinical Chemistry and Laboratory Medicine, Vol. 50, No. 9, 01.09.2012, p. 1565-1571.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Improvement in the performance of external quality assessment in Korean HIV clinical laboratories using unrecalcified human plasma

AU - Wang, Jin Sook

AU - Kee, Mee Kyung

AU - Choi, Byeong Sun

AU - Kim, Chan Wha

AU - Kim, Hyon Suk

AU - Kim, Sung Soon

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Background: The external quality assessment schemes (EQAS) organizer provides a suitable program to monitor and improve the quality of human immunodeficiency virus (HIV) testing laboratories with EQAS panels prepared under various conditions. The aim of the current study was to investigate the effects of human plasma samples on the EQAS results of HIV obtained from hospital-based clinical laboratories. Methods: From 2007 to 2009, HIV EQAS panels consisted of four to six samples that consisted of undiluted positive and negative samples and were provided to laboratories twice per year. Up until the first half EQAS in 2008, EQAS panel materials were obtained by converting acid citrate dextrose treated plasma to serum via chemical treatment with CaCl 2. Beginning with the second EQAS in 2008, all materials were prepared without the defibrination process. Results: Approximately 300 HIV clinical laboratories participated in this program. The overall performance of clinical laboratories was shown to be improved when using unrecalcified plasma panels compared with recalcified panels. Significant differences were observed in EIA analyses of plasma for both positive (p < 0.001) and negative (p < 0.001) samples between the recalcified and unrecalcified groups. Conclusions: Our finding suggested that defibrination status of EQAS panels might affect the results of anti-HIV EQAS of Korean HIV testing laboratories.

AB - Background: The external quality assessment schemes (EQAS) organizer provides a suitable program to monitor and improve the quality of human immunodeficiency virus (HIV) testing laboratories with EQAS panels prepared under various conditions. The aim of the current study was to investigate the effects of human plasma samples on the EQAS results of HIV obtained from hospital-based clinical laboratories. Methods: From 2007 to 2009, HIV EQAS panels consisted of four to six samples that consisted of undiluted positive and negative samples and were provided to laboratories twice per year. Up until the first half EQAS in 2008, EQAS panel materials were obtained by converting acid citrate dextrose treated plasma to serum via chemical treatment with CaCl 2. Beginning with the second EQAS in 2008, all materials were prepared without the defibrination process. Results: Approximately 300 HIV clinical laboratories participated in this program. The overall performance of clinical laboratories was shown to be improved when using unrecalcified plasma panels compared with recalcified panels. Significant differences were observed in EIA analyses of plasma for both positive (p < 0.001) and negative (p < 0.001) samples between the recalcified and unrecalcified groups. Conclusions: Our finding suggested that defibrination status of EQAS panels might affect the results of anti-HIV EQAS of Korean HIV testing laboratories.

UR - http://www.scopus.com/inward/record.url?scp=84867780254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867780254&partnerID=8YFLogxK

U2 - 10.1515/cclm-2011-0943

DO - 10.1515/cclm-2011-0943

M3 - Article

C2 - 23089539

AN - SCOPUS:84867780254

VL - 50

SP - 1565

EP - 1571

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 9

ER -